Amy McCurley, Ph.D. is currently a Director at Omega Therapeutics. She has a received Doctor of Philosophy from Boston University. Her research interests are Molecular Biology, Cell Culture, Immunohistochemistry, Molecular Cloning, Fibrotic and Rare Diseases, Gene Therapy, Biologics, Antisense Oligonucleotides, Small Molecules.